Follow
Yingfang He
Yingfang He
PhD candidate, ETH Zurich
Verified email at pharma.ethz.ch
Title
Cited by
Cited by
Year
Tetrahydroindazolone substituted 2-aminobenzamides as fluorescent probes: switching metal ion selectivity from zinc to cadmium by interchanging the amino and carbamoyl groups …
J Jia, QC Xu, R Li, X Tang, YF He, MY Zhang, Y Zhang, GW Xing
Organic & Biomolecular Chemistry 10 (31), 6279-6286, 2012
362012
1-(4-[18F]Fluorobenzyl)-4-[(tetrahydrofuran-2-yl)methyl]piperazine: A Novel Suitable Radioligand with Low Lipophilicity for Imaging σ1 Receptors in the Brain
Y He, F Xie, J Ye, W Deuther-Conrad, B Cui, L Wang, J Lu, J Steinbach, ...
Journal of medicinal chemistry 60 (10), 4161-4172, 2017
282017
18F-Labeled indole-based analogs as highly selective radioligands for imaging sigma-2 receptors in the brain
L Wang, J Ye, Y He, W Deuther-Conrad, J Zhang, X Zhang, M Cui, ...
Bioorganic & medicinal chemistry 25 (14), 3792-3802, 2017
202017
Development of high brain-penetrant and reversible monoacylglycerol lipase PET tracers for neuroimaging
Y He, M Schild, U Grether, J Benz, L Leibrock, D Heer, A Topp, L Collin, ...
Journal of medicinal chemistry 65 (3), 2191-2207, 2022
112022
Positron Emission Tomography Imaging Evaluation of a Novel 18F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys
H Jia, Z Cai, D Holden, Y He, S Lin, S Li, E Baum, A Shirali, M Kapinos, ...
ACS Chemical Neuroscience 11 (11), 1673-1681, 2020
112020
Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A‐selective nuclear imaging probes
Y He, L Mu, SM Ametamey, R Schibli
Journal of Labelled Compounds and Radiopharmaceuticals 62 (8), 552-560, 2019
82019
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold
Y He, LC Gobbi, AM Herde, D Rombach, M Ritter, B Kuhn, MB Wittwer, ...
Nuclear Medicine and Biology 108, 24-32, 2022
72022
Synthesis and evaluation of new 1-oxa-8-azaspiro [4.5] decane derivatives as candidate radioligands for sigma-1 receptors
J Tian, Y He, W Deuther-Conrad, H Fu, F Xie, Y Zhang, T Wang, X Zhang, ...
Bioorganic & Medicinal Chemistry 28 (14), 115560, 2020
72020
Ketamine and ceftriaxone-induced alterations in glutamate levels do not impact the specific binding of metabotropic glutamate receptor subtype 5 radioligand [18F] PSS232 in the …
A Müller Herde, SD Boss, Y He, R Schibli, L Mu, SM Ametamey
Pharmaceuticals 11 (3), 83, 2018
72018
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain
Y He, U Grether, MF Taddio, C Meier, C Keller, MR Edelmann, M Honer, ...
European Journal of Medicinal Chemistry 243, 114750, 2022
52022
Radiolabeled compounds
L Collin, M Edelmann, L Gobbi, U Grether, T Hartung, HE Yingfang, ...
US Patent App. 17/692,632, 2022
52022
Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer’s disease: A [18F]PSS232 PET/MRI study
J Wang, Y He, X Chen, L Huang, J Li, Z You, Q Huang, S Ren, K He, ...
Alzheimer's Research & Therapy 16 (1), 9, 2024
42024
Proof-of-concept optimization of a copper-mediated 18 F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation
Y Lu, Y He, R Schibli, L Mu, RM van Dam
Lab on a Chip 23 (21), 4652-4663, 2023
22023
Evaluation of 5H‐Thiazolo[3,2‐α]pyrimidin‐5‐ones as Potential GluN2A PET Tracers
Y He, DM Whitehead, E Briard, S Numao, L Mu, R Schibli, SM Ametamey, ...
ChemMedChem 15 (24), 2448-2461, 2020
22020
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2
J Wang, D Beyer, C Vaccarin, Y He, M Tanriver, R Benoit, X Deupi, L Mu, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-13, 2024
12024
Identification of (R)-[18F] YH134 for monoacylglycerol lipase neuroimaging and exploration of its use for central nervous system and peripheral drug development
Y He, SD Krämer, U Grether, MB Wittwer, L Collin, B Kuhn, A Topp, ...
Journal of Nuclear Medicine 65 (2), 300-305, 2024
12024
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s …
J Aebi, K Atz, SM Ametamey, J Benz, J Blaising, S Butini, G Campiani, ...
Chimia 78 (7-8), 499-512, 2024
2024
Magl inhibitors
LC Gobbi, UM Grether, HE Yingfang, B Kuhn, L Mu
US Patent App. 18/593,350, 2024
2024
Evaluation of 11C-YH168 as a novel radiotracer for monoacylglycerol lipase and comparison with 18F-T401 in non-human primates
MQ Zheng, J GU, D Holden, Y He, H Gao, H Zhang, M Crosby, J Ropchan, ...
Journal of Nuclear Medicine 65 (supplement 2), 242296-242296, 2024
2024
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[11C]YH132: Application in Drug Development and Neurodegenerative Diseases
Y He, A Delparente, CVML Jie, C Keller, R Humm, D Heer, L Collin, ...
ChemBioChem 25 (7), e202300819, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20